Suven Life Sciences has received grant for three product patents one each from Australia, Sri Lanka and South Korea corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029.
https://www.epicresearch.co/
0731-664-2300
https://www.epicresearch.co/
0731-664-2300
0 comments:
Post a Comment